New approach to stop most-wanted cancer protein

A specially crafted compound that targets the protein MYCN in cancer cells can disrupt the protein's ability to stimulate tumor growth.

Combination treatments show promise for metastatic melanoma

Combination treatments show promise for metastatic melanoma

Nivolumab and dabrafenib plus trametinib up survival in melanoma without, with BRAF, respectively.

Inadequately management of hot flushes leave women vulnerable

More than 70% of women who have had breast cancer experience menopausal problems, hot flushes in particular, and some cancer survivors consider giving up their post cancer medication to mitigate these conditions.

Improved survival in pediatric umbilical cord transplants for hematologic cancers

A new standard of care for children facing acute myeloid leukemia (AML) may be clear, following a multiyear study.

Radiation exposure linked to aggressive thyroid cancers

For the first time, researchers have found that exposure to radioactive iodine is associated with more aggressive forms of thyroid cancer, according to a careful study of over a thousand individuals.

Variation seen in number of cancer survivors undergoing HIV testing

Variation seen in number of cancer survivors undergoing HIV testing

Proportion undergoing testing varies by demographic and health-related factors, and by state, a study found.

Proton therapy less costly than some alternative radiotherapy techniques

Partial breast irradiation (APBI) with proton therapy, as opposed to whole breast irradiation (WBI), may prove more affordable and have a more beneficial length of treatment for patients with early stage breast cancer.

Postoperative radiation therapy improves overall survival in resected NSCLC

Patients with non-small lung cancer (NSCLC) that received postoperative radiation therapy (PORT) lived an average of 4 months longer, when compared with patients who had the same disease progression and treatment criteria.

Most internet sites on prostate cancer disagree with expert panel's recommendations

Less than 20 percent of top-ranked health sites advise against screening for prostate cancer, a recommendation made by the USPSTF.

Circulating tumor cells can reveal cancer sooner than imaging tests

Circulating tumor cells can be detected well before the cancer becomes detectable on computed tomography (CT), according to new research, opening the possibility of early eradication of the primary cancer site.

Conference Coverage

Early palliative care can cut hospital readmissions for cancer patients

A new, collaborative model in cancer care aims to reduce the rates at which patients go to intensive care or are readmitted to the hospital after discharge.

3-D printed facial prosthesis offers new hope for eye cancer patients after surgery

By utilizing both facial scanning software and 3-D printing, researchers have developed an inexpensive way to make facial prostheses for patients with eye cancer.

Subsidies help breast cancer patients adhere to hormone therapy

A federal prescription-subsidy program for low-income Medicare recipients has increased adherence to hormone therapy to prevent breast cancer recurrence after surgery, according to recent data.

New test helps in choosing best treatment for ovarian cancer

Researchers have devised a new test to help doctors diagnose ovarian tumors and choose the most appropriate treatment.

ASCO: Burnout prevalent among palliative care clinicians

A majority of of palliative care clinicians report burnout, according to a study, with the greatest risk of burnout for younger clinicians and those working more than 50 hours per week

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs